Vivani Medical Inc
VANI
Company Profile
Business description
Vivani Medical Inc is a clinical-stage biopharmaceutical company whose primary focus is the development of miniature subdermal drug implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases with once or twice-yearly administration. Its flagship drug implant candidates are designed to improve medication adherence and provide smooth, consistent therapeutic levels of GLP-1, the same class of active pharmaceutical ingredients used in Ozempic, Trulicity, and Wegovy.
Contact
1350 South Loop Road
AlamedaCA94502
USAT: +1 415 506-8462
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
36
Stocks News & Analysis
stocks
Does SpaceX’s sky-high valuation make sense?
SpaceX’s $1.5 trillion valuation looks expensive and risky, but not irrational.
stocks
ASX healthcare leader sees further cuts to fair value
Fiercer competition expected to squeeze margins.
stocks
Avoid this overpriced ASX share
This ASX share is 84% overvalued and lacks a sustainable competitive advantage.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,976.80 | 20.70 | 0.23% |
| CAC 40 | 7,982.93 | 10.56 | -0.13% |
| DAX 40 | 23,588.79 | 379.84 | -1.58% |
| Dow JONES (US) | 47,706.51 | 34.29 | -0.07% |
| FTSE 100 | 10,321.39 | 90.85 | -0.87% |
| HKSE | 25,898.76 | 61.14 | -0.24% |
| NASDAQ | 22,697.10 | 1.16 | 0.01% |
| Nikkei 225 | 55,025.37 | 776.98 | 1.43% |
| NZX 50 Index | 13,293.13 | 198.76 | 1.52% |
| S&P 500 | 6,781.48 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,743.50 | 19.40 | 0.22% |
| SSE Composite Index | 4,133.43 | 10.29 | 0.25% |